TY - JOUR T1 - ABCG2- and ABCB1 Inhibition Using Supratherapeutic Doses of Erlotinib: Clinical Implications in the Treatment of Central Nervous System Metastases JF - Journal of Nuclear Medicine JO - J Nucl Med SP - 305 LP - 305 DO - 10.2967/jnumed.119.235705 VL - 61 IS - 2 AU - Eveline A. van de Stadt AU - Maqsood Yaqub AU - Idris Bahce AU - N.H. Hendrikse Y1 - 2020/02/01 UR - http://jnm.snmjournals.org/content/61/2/305.abstract N2 - ER -